Shipped cold to your door  ·  Lyophilized vialsQuestions? WhatsApp +62 811 2120 5090
A woman sitting quietly on a bench facing the mountains at dusk
Cognitive

Cerebrolysin and Pinealon: two different approaches in cognitive research

17 August 2026

Cerebrolysin and Pinealon draw the attention of those of you who follow research on cognition and brain function. The two are placed close together in the catalog, but their approaches differ: their molecular form, the way the studies are carried out, and their research track record. Knowing these differences helps you read their two product pages more clearly.

If the term peptide still feels new, Peptides for beginners: where to start can help give basic context before you explore these two product pages.

Two different molecular forms

Cerebrolysin is a mix of small peptides and amino acids. The compound has been studied through a series of clinical trials in several countries. Because it is a mixture, the discussion around it differs from that of a single molecule.

Pinealon sits at the other end. It is a short tripeptide with the sequence Glu-Asp-Arg. One is a mixture with many components, the other a small molecule with a clear sequence. This basic difference also explains why the research questions and the form of the data for the two cannot be swapped.

CompoundWhat is available from its research
CerebrolysinA mix of small peptides and amino acids, with a review of several randomized controlled trials.
PinealonThe tripeptide Glu-Asp-Arg, studied in laboratory research and one report in humans.
Summary of form and research track record

The research track record of each

A PubMed search for Cerebrolysin returns dozens of publications. The 2019 Cochrane review brought together six randomized controlled trials with a total of 597 participants, carried out in China, Russia, and Romania.

Pinealon has a more compact track record, four publications in Russian-language gerontology journals. Most of its data comes from laboratory research, including experiments under conditions of oxygen deficiency, and there is also a report in humans with 32 participants aged 41 to 83. Many of its publications come from one and the same research school.

Why both attract interest

Cerebrolysin is interesting because it has already been studied in clinical trials in several countries, while Pinealon is interesting because of its very compact form, just three amino acids. These two kinds of appeal are different, so the two are better read side by side than compared directly.

How to read these two catalog pages

Start with the information on form and contents on each product page. Cerebrolysin is widely discussed in clinical research outside Indonesia, while Pinealon is known from short-peptide research. For a framework for reading product information, see A guide to reading peptide product information.

Full details on Cerebrolysin and Pinealon are in the Peptivia catalog. If there is anything you would like to ask before ordering, the Peptivia team is ready to help through Peptivia's official WhatsApp.

Frequently asked questions
What is the difference between Cerebrolysin and Pinealon?

Cerebrolysin is a mix of small peptides and amino acids studied in several clinical trials, while Pinealon is a short tripeptide with the sequence Glu-Asp-Arg. Their molecular form, study context, and research track record differ, so the two are read as two separate approaches.

Why are Cerebrolysin and Pinealon in the cognitive group?

Both are studied in research related to brain function. Cerebrolysin through clinical trials in several countries, Pinealon through short-peptide research and one report in 32 participants.

Peptides in this article

Still deciding which one fits? Tell us your goal and we will help you narrow it down.

Chat on WhatsApp